Metraipolis › archive › dc_d1e00fb8e899

Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites — Europe PMC PMID:42435328

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42435328
DOI
10.1002/ueg2.70258
License (as archived)
solo-consultazione
Archived
2026-10-18T14:15:28.641Z
SHA-256 of the archived text
a4038aee1542a606ffbfa6ee2602ed2357e67239fc00909ab8797245d7e2a864
Stable URL of this page
https://metraipolis.com/documento/dc_d1e00fb8e899

How to cite

Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites — Europe PMC PMID:42435328 — Europe PMC (en), https://europepmc.org/article/MED/42435328 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d1e00fb8e899 (Metraipolis archive dc_d1e00fb8e899, sha256 a4038aee1542a606ffbfa6ee2602ed2357e67239fc00909ab8797245d7e2a864)
BibTeX
@misc{dcd1e00fb8e899,
  title = {Pre-Treatment Serum Albumin Concentration Predicts Clinical Benefit of Long-Term Albumin in Patients With Cirrhosis and Ascites — Europe PMC PMID:42435328},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42435328},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d1e00fb8e899; sha256 a4038aee1542a606ffbfa6ee2602ed2357e67239fc00909ab8797245d7e2a864},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42435328. Agents can read the archived copy with the MCP tool read_document.